文献速递神经免疫

季节性流感疫苗与吉兰-巴雷综合征:自身对照病例系列研究

Seasonal influenza vaccine and Guillain-Barré syndrome: A self-controlled case series study.
PubMed 文献 · Neurology · 2020-02-25

基于法国2010至2014年四个流感季的全国数据,采用自身对照病例系列法分析3523例吉兰-巴雷综合征(GBS)病例。疫苗接种后42天内GBS风险未显著升高(调整后IRR 1.10,95%CI 0.89-1.37),而急性呼吸道或胃肠道感染后风险约增四倍。

要点

  • 季节性流感疫苗接种后42天内未观察到GBS风险显著增加。
  • 急性呼吸道感染后GBS风险约增四倍(IRR 3.89)。
  • 急性胃肠道感染后GBS风险约增四倍(IRR 3.64)。

核心结论

  • 季节性流感疫苗接种后42天内未显示与吉兰-巴雷综合征存在关联。

研究设计与样本

  • 研究基于法国全国健康数据系统,纳入2010年至2014年每年9月1日至3月31日期间发生的GBS病例,采用自身对照病例系列法分析。
  • 共纳入3523例GBS病例,其中15%(527例)曾接种流感疫苗,140例在接种后42天内发生GBS。

主要发现

  • 接种流感疫苗后42天内GBS粗风险未显著增加(IRR 1.02;95%CI 0.83-1.25;p=0.85)。
  • 调整日历月份及急性胃肠道和呼吸道感染发生率后,结果仍不显著(IRR 1.10;95%CI 0.89-1.37;p=0.38)。
  • 急性呼吸道感染后GBS风险约增四倍(IRR 3.89;95%CI 3.52-4.30;p<0.0001)。
  • 急性胃肠道感染后GBS风险约增四倍(IRR 3.64;95%CI 3.01-4.40;p<0.0001)。

临床怎么用

  • 该研究结果支持季节性流感疫苗接种后GBS风险无显著增加,可为疫苗接种获益风险评估提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the risk of Guillain-Barré syndrome (GBS) following seasonal influenza vaccination based on French nationwide data. METHODS: All cases of GBS occurring in metropolitan France between September 1 and March 31 from 2010 to 2014 were identified from the French national health data system. Data were analyzed according to the self-controlled case series method. The risk period started 1 day after the patient received vaccine (D1) until 42 days after vaccination (D42). The incidence of GBS during this risk period was compared to that of the control period (D43-March 31). The incidence rate ratio (IRR) was estimated after adjusting for seasonality and presence or not of acute infections. RESULTS: Between September and March, of the 2010/2011 to 2013/2014 influenza vaccination seasons, 3,523 cases of GBS occurred in metropolitan France and were included in the study. Among them, 15% (527 patients) had received influenza vaccination. A total of 140 patients developed GBS during the 42 days following influenza vaccination. The crude risk of developing GBS was not significantly increased during the 42 days following influenza vaccination (IRR, 1.02; 95% confidence interval [CI], 0.83-1.25; p = 0.85). This result remained nonsignificant after adjustment for calendar months and the incidence of acute gastrointestinal and respiratory tract infections (IRR, 1.10; 95% CI, 0.89-1.37; p = 0.38). In contrast, the risk of GBS was fourfold higher after acute respiratory tract infection (IRR, 3.89; 95% CI, 3.52-4.30; p < 0.0001) or gastrointestinal infection (IRR, 3.64; 95% CI, 3.01-4.40; p < 0.0001). CONCLUSIONS: No association between seasonal influenza vaccination and GBS was shown during the 42 days following vaccination.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Grave C, Boucheron P, Rudant J, et al. Seasonal influenza vaccine and Guillain-Barré syndrome: A self-controlled case series study. Neurology. 2020. PMID: 32098853. doi:10.1212/WNL.0000000000009180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。